Explore our featured news items here. Subscribe to stay informed of all information shared and published by OHC.
Sponsor appreciation:
You’re invited to explore and join Physician Factor, a knowledge exchange network is a dedicated portal for physicians seeking opportunities to contribute their expertise and input in exchange for compensation and supplemental income.
You can search articles using your own keywords or the following tags: Lung Cancer | Breast Cancer | Drugs and Therapies | Cancer General
How Serious Is FDA Warning About Revolutionary Blood-Cancer Treatment?
The Food and Drug Administration announced in December 2023 that it’s investigating reports of secondary cancers in patients who received CAR T-cell therapy, one of a suite of immunotherapies that have revolutionized cancer care over the past decade. The treatment reprograms a patient’s T cells, a key part of the immune system, to recognize and attack cancer cells.